Spine
In the realm of spinal fusion surgery, the quest for faster, safer, and more reliable bone formation has led to…
The global kyphosis market is anticipated to grow at a compound annual growth rate of 11.4 percent between 2016 and 2022, based on a Market Research Future report, according to Yahoo! Finance.
A new study published in Spine examines how frailty impacts complications and mortality after adult spinal deformity.
Here are four spine surgeons who made headlines during the week of Dec. 9, 2016.
Eric Oliver
Five spine surgeons discuss spinal imaging and the advancements they would like to see.
The global minimally invasive spine surgery market will likely grow at a compound annual growth rate of 7.57 percent between 2016 and 2020, based on a ResearchMoz report, according to medGadget.
Here are eight things for spinal surgeons to know for Dec. 8, 2016.
A new study published in Spine compares posterolateral fusion with interbody fusion for patients with degenerative spondylolisthesis.
Chesterfield, U.K.-based Mallinckrodt Pharmaceuticals reported results from a study of the company's OFIRMEV (acetaminophen) injections. OFIRMEV is the only intravenous formulation of acetaminophen that is FDA approved and marketed in the United States. The study compared the use of oral…
An infant with spinal muscular atrophy type 1 became the first baby to receive an experimental drug, nusinersen, to treat her condition in 2013, according to Medical Xpress.
James Fish, DO, affiliated with The Hughston Clinic in Nashville, Tenn., performed Rutherford County's first two-level cervical disc replacement, according to WGNS News Radio.
